Lead optimization of 4-(thio)-chromenone 6-O-sulfamate analogs using QSAR, molecular docking and DFT – a combined approach as steroidal sulfatase inhibitors

References

• Santner SJ, Feil PD, Santen RJ. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab. 1984;59:29–33.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA A Cancer J Clin. 2019;69:438–451.
   PubMed Web of Science ®Google Scholar
• Africander D, Storbeck KH. Steroid metabolism in breast cancer: where are we and what are we missing? Mol Cell Endocrinol. 2018;466:86–97.
   PubMed Web of Science ®Google Scholar
• Kathiravan MK, Kale AN, Nilewar S. Discovery and development of topoisomerase inhibitors as anticancer agents. Mini Rev Med Chem. 2016;16:1219–1229.
   PubMed Web of Science ®Google Scholar
• Converse A, Zhang C, Thomas P. Membrane androgen receptor ZIP9 induces croaker ovarian cell apoptosis via stimulatory G protein alpha subunit and MAP kinase signaling. Endocrinology. 2017;158:3015–3029.
   PubMed Web of Science ®Google Scholar
• Volkova YA, Kozlov AS, Kolokolova MK, et al. Steroidal N-sulfonylimidates: synthesis and biological evaluation in breast cancer cells. Eur J Med Chem. 2019;179:694–706.
   PubMed Web of Science ®Google Scholar
• Miller P, Kidwell KM, Thomas D, et al. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome. Breast Cancer Res Treat. 2017;166:85–94.
   PubMed Web of Science ®Google Scholar
• Kozak W, Daśko M, Masłyk M, et al. Phosphate tricyclic coumarin analogs as steroid sulfatase inhibitors: synthesis and biological activity. RSC Adv. 2014;4:44350–44358.
   Web of Science ®Google Scholar
• Nishimura R, Anan K, Yamamoto Y, et al. Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: results of the JMTO BC08-01 phase II trial. Oncol Rep. 2013;29:1707–1713.
   PubMed Web of Science ®Google Scholar
• Kajita D, Nakamura M, Matsumoto Y, et al. Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character. Bioorg Med Chem. 2014;22:2244–2252.
   PubMed Web of Science ®Google Scholar
• Thomas MP, Potter BV. Discovery and development of the aryl O-sulfamate pharmacophore for oncology and women’s health. J Med Chem. 2015;58:7634–7658.
   PubMed Web of Science ®Google Scholar
• Chetrite GS, Cortes-Prieto J, Philippe JC, et al. Comparison of estrogen concentrations, estronesulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid BiochemMol Biol. 2000;72:23–27.
   PubMed Web of Science ®Google Scholar
• Woo LW, Howarth NM, Purohit A, et al. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. J Med Chem. 1998;41:1068–1083.
   PubMed Web of Science ®Google Scholar
• Chitre TS, Kathiravan MK, Bothara KG, et al. Pharmacophore optimization and design of competitive inhibitors of thymidine monophosphate kinase through molecular modeling studies. Chem Biol Drug Des. 2011;78:826–834.
   PubMed Web of Science ®Google Scholar
• Nilewar SS, Kathiravan MK. 3D CoMFA, CoMSIA, topomer CoMFA and HQSAR studies on aromatic acid esters for carbonic anhydrase inhibitory activity. J Chemometrics. 2014;28:60–70.
   Web of Science ®Google Scholar
• Pommier Y, Leo E, Zhang H, et al. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010;17:421–433.
   PubMed Web of Science ®Google Scholar
• Gopinath P, Kathiravan MK. QSAR and docking studies on triazole benzene sulfonamides with human carbonic anhydrase IX inhibitory activity. J.Chemom. 2019;12:33.
   Google Scholar
• Gramatica P, Chirico N, Papa E, et al. QSARINS: a new software for the development, analysis, and validation of QSAR MLR models. J Comput Chem. 2013;34:2121–2132.
   Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem. 2009;30:2785–2791.
   PubMed Web of Science ®Google Scholar
• Spessard GO. ACD Labs/LogP dB 3.5 and ChemSketch 3.5. J Chem Inf Comput Sci. 1998;38:1250–1253.
   Google Scholar
• Hanwell MD, Curtis DE, Lonie DC, et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012;4:17.
   PubMed Web of Science ®Google Scholar
• Nussbaumer P, Lehr P, Billich A. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase. J Med Chem. 2002;45:4310–4320.
   PubMed Web of Science ®Google Scholar
• O'Boyle NM, Banck M, James CA, et al. Open Babel: an open chemical toolbox. J Cheminform. 2011;3:33.
   PubMed Web of Science ®Google Scholar
• Leonard JT, Roy K. On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci. 2006;25:235–251.
   Google Scholar
• Yap CW. PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J Comput Chem. 2011;32:1466–1474.
   PubMed Web of Science ®Google Scholar
• Kier LB, Hall LH. An electrotopological-state index for atoms in molecules. Pharm Res. 1990;07:801–807.
   Google Scholar
• Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci. 2007;26:694–701.
   Google Scholar
• Webb GI, Sammut C, Perlich C, et al. Leave-one-out cross-validation. Encyclopedia of machine learning. Boston (MA): Springer; 2011.
   Google Scholar
• Rücker C, Rücker G, Meringer M. y-Randomization and its variants in QSPR/QSAR. J Chem Inf Model. 2007;47:2345–2357.
   PubMed Web of Science ®Google Scholar
• Morris GM, Lim-Wilby M. Molecular docking. Methods Mol Biol. 2008;443:365–382.
   PubMedGoogle Scholar
• Salentin S, Schreiber S, Haupt VJ, et al. PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res. 2015;43:W443–W447.
   PubMed Web of Science ®Google Scholar
• Renner S, Schneider G. Scaffold-hopping potential of ligand-based similarity concepts. ChemMedChem. 2006;1:181–185.
   PubMed Web of Science ®Google Scholar
• Theivendren P, Kunjiappan S, Govindraj S, et al. Graph theoretical analysis, insilico modeling and formulation of pyrimidine nanoparticles as p38α MAP kinases inhibitors: a quantitative proteomics approach. Drug Res (Stuttg). 2019;69:100–110.
   PubMed Web of Science ®Google Scholar
• Calais JL. Density-functional theory of atoms and molecules. R.G. Parr and W. Yang, Oxford University Press, New York, Oxford, 1989. Int J Quantum Chem. 1993;47:101–101.
   Google Scholar